The current Zeitgeist favouring utilitarian research risks undermining basic research—the very foundation on which innovative technological advances depend.
By Nektarios Tavernarakis:
www.embopress.org/doi/full/10....
The current Zeitgeist favouring utilitarian research risks undermining basic research—the very foundation on which innovative technological advances depend.
By Nektarios Tavernarakis:
www.embopress.org/doi/full/10....
www.theglobeandmail.com/business/art...
www.theglobeandmail.com/business/art...
ir.reparerx.com/news-release...
ir.reparerx.com/news-release...
Reverb Therapeutics closes $17-million seed round led by Amplitude Ventures betakit.com/reverb-thera...
#biotechfeed
Reverb Therapeutics closes $17-million seed round led by Amplitude Ventures betakit.com/reverb-thera...
#biotechfeed
Reverb Therapeutics closes $17-million seed round led by Amplitude Ventures betakit.com/reverb-thera...
Reverb Therapeutics closes $17-million seed round led by Amplitude Ventures betakit.com/reverb-thera...
Not only has it been Looked Into it has been MAXIMALLY Looked Into. In fact, there is almost nowhere left to look.
In 2019, a study came out that was simply titanic…
Not only has it been Looked Into it has been MAXIMALLY Looked Into. In fact, there is almost nowhere left to look.
In 2019, a study came out that was simply titanic…
Escient - acquired by $INCY for $750M in April
Septerna - $331M IPO last week $SEPN
Evommune $115M Series C today
endpts.com/startup-evom...
Escient - acquired by $INCY for $750M in April
Septerna - $331M IPO last week $SEPN
Evommune $115M Series C today
endpts.com/startup-evom...